Cancer of the Lung, Lung Cancer
Conditions
Keywords
Lung cancer screening (LCS), Pink and Pearl Campaign, Breast cancer screening (BCS), Low-dose computed tomography (LDCT), Smoking history, Health disparities, Screening behavior, Feasibility, Acceptability, Appropriateness
Brief summary
Inspired by the ongoing Pink & Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer Center to pilot this campaign in its mammography clinics in order to promote awareness, referral, and completion of lung cancer screening (LCS) among eligible women. This campaign leverages established infrastructure such as nurse navigation and referral to screening or primary care for further shared decision-making on cancer screening. The purpose of this study is to evaluate the effectiveness of the Pink & Pearl Campaign in improving LCS uptake among LCS-eligible women undergoing mammography at Christian Hospital. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, our specific aims for this proposal are to: a) assess whether the Pink & Pearl Campaign increases referrals and uptake/completion of LCS among LCS-eligible women undergoing screening mammography; b) determine median time-to-screening after referral to LCS; and c) evaluate individual and health system factors influencing LCS uptake and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.
Interventions
OTHERPink and Pearl Campaign
This campaign leverages established infrastructure such as nurse navigation and referral to screening or primary care for further shared decision-making on cancer screening.
Sponsors
Washington University School of Medicine
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Eligibility Criteria - Interventional Study * Undergoing screening mammography at Christian Hospital * Between the ages of 50-80 years (inclusive) Eligibility Criteria - Survey and Interview Sub-Studies * Part of the interventional study * Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years * Can speak and understand English * Not diagnosed with a serious health problem that will limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year) * Willing and able to get treatment if lung cancer is found * Able to understand and willing to sign an IRB-approved written informed consent document Eligibility Criteria - Providers * At least 20 years of age * Involved in the breast radiology service or referred at least one patient to the Pink \& Pearl Campaign * Able to provide verbal consent to participate in the interview
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of women referred from the breast radiology service who successfully complete LCS 6-months post-Pink & Pearl implementation | At 6 months | The investigators will compare the baseline prevalence of LCS among women undergoing BCS to the prevalence of LCS among women undergoing BCS 6 months after implementation of the Pink \& Pearl Campaign. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Median time-to-screening | At 6 months | The investigators will compare differences in time-to-lung cancer screening across heterogenous populations |
| Acceptability of Pink & Pearl Campaign | At 6 months | Defined as the perception that the campaign is agreeable or satisfactory |
Countries
United States
Contacts
CONTACTBeryne Odeny, M.D., MPH, Ph.D.
CONTACTMichelle V Lee, M.D.
PRINCIPAL_INVESTIGATORBeryne Odeny, M.D., MPH, Ph.D.
Washington University School of Medicine
Outcome results
None listed